Tan Justina Angel, Koh Jin Hean, Merchant Reshma Aziz, Tan Li Feng
Department of Geriatric Medicine, Alexandra Hospital, Singapore.
Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Geriatr Gerontol Int. 2025 Jan;25(1):102-107. doi: 10.1111/ggi.15025. Epub 2024 Nov 24.
Frailty is highly prevalent in old age and is associated with a high risk of mortality. Few studies have evaluated frailty as a predictor of mortality in the oldest old. This systematic review and meta-analysis aims to determine the mortality risk associated with frailty in this age group.
An electronic systemic literature search was performed in May 2023 on three databases (Medline/PubMed, Embase, and Cochrane Library) for studies investigating the risk of mortality with frailty. A meta-analysis was done to calculate pooled mortality estimates.
Frail participants had significantly lower overall survival (OS) compared with non-frail participants (hazard ratio [HR]: 1.81; 95% confidence interval [CI]: 1.32 to 2.50; P < 0.01, I = 100%; risk ratio [RR]: 4.15; 95% CI: 2.50 to 6.88; P < 0.01, I = 97%). Among participants aged 90 and above, a higher percentage of male participants was associated with poorer OS in frail participants. While the pooled association of frailty with OS remained significant across studies in participants aged less than 90 years old (HR: 2.09; 95% CI: 1.55 to 2.82; I = 75%), frailty was not significantly associated with OS in studies for participants aged 90 and above. The pooled association of frailty with OS was only significant for the Fried Frailty Phenotype (HR: 2.73; 95% CI: 1.05 to 7.12; I = 93%) and not for the Frailty Index. The pooled association also remained significant among studies that adjusted for age (HR: 1.74; 95% CI: 1.50 to 2.02; I = 0%) and sex (HR: 1.77; 95% CI: 1.48 to 2.11; I = 94%) as a covariate.
Frailty was significantly associated with a poorer OS in participants below the age of 90. This association was not statistically significant in those older than 90 years, with sex-differentiated effects observed. Geriatr Gerontol Int 2025; 25: 102-107.
衰弱在老年人中非常普遍,且与高死亡风险相关。很少有研究评估衰弱作为最年长者死亡预测因素的情况。本系统评价和荟萃分析旨在确定该年龄组中与衰弱相关的死亡风险。
2023年5月在三个数据库(Medline/PubMed、Embase和Cochrane图书馆)中进行了电子系统文献检索,以查找调查衰弱与死亡风险的研究。进行荟萃分析以计算合并死亡率估计值。
与非衰弱参与者相比,衰弱参与者的总生存期(OS)显著更低(风险比[HR]:1.81;95%置信区间[CI]:1.32至2.50;P < 0.01,I = 100%;风险率[RR]:4.15;95%CI:2.50至6.88;P < 0.01,I = 97%)。在90岁及以上的参与者中,衰弱参与者中男性参与者比例较高与较差的总生存期相关。虽然在年龄小于90岁的参与者的各项研究中,衰弱与总生存期的合并关联仍然显著(HR:2.09;95%CI:1.55至2.82;I = 75%),但在针对90岁及以上参与者的研究中,衰弱与总生存期无显著关联。衰弱与总生存期的合并关联仅对弗里德衰弱表型显著(HR:2.73;95%CI:1.05至7.12;I = 93%),而对衰弱指数不显著。在将年龄(HR:1.74;95%CI:1.50至2.02;I = 0%)和性别(HR:1.77;95%CI:1.48至2.11;I = 94%)作为协变量进行调整的研究中,合并关联也仍然显著。
衰弱与90岁以下参与者较差的总生存期显著相关。在90岁以上者中,这种关联无统计学意义,且观察到了性别差异效应。《老年医学与老年病学国际杂志》2025年;25:102 - 107。